Skip to main content
Clinical Trials/NCT03206853
NCT03206853
Unknown
Not Applicable

Clinical Trail of Hybrid Operating Technique in Management of Complex Intracranial Aneurysms With Coexistence of Multiple Risk Factors

liuxingju1 site in 1 country258 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intracranial Aneurysm
Sponsor
liuxingju
Enrollment
258
Locations
1
Primary Endpoint
operation-related mortality rate
Last Updated
8 years ago

Overview

Brief Summary

To evaluate the clinical benefits and risks of hybrid operating techniques in management of complex intracranial aneurysms, which could coexists with multiple risk factors.

Detailed Description

Purpose: Have an evaluation of clinical benefits and risks of hybrid operating techniques in management of complex intracranial aneurysms (CIAs), which could coexists with multiple risk factors. Meanwhile, as a new cooperative interventional modality, optimized workflows, technical key knots and operation routines will be explored in the study. Objects: Patients with CIAs, coincident with inclusion and exclusion criterion and admitted in participating organizations. Methods: Patients will be distributed into 2 groups, including traditional therapy group(control group) and hybrid operating group(trial group), and conduct with traditional neurosurgical management or one-stage hybrid operating management correspondingly. Peri-operative mortality rate is considered to be the primary observing indicator, and morbidity rate of peri-operative cerebral hemorrhagic/ischemic event, morbidity rate of aneurysmal residuals, morbidity rate of neural functional deteriorations, and health-economic indicators are secondary indicators.The information of operations will be recorded in detail as evidence of optimization of workflow and technical key knots.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
December 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
liuxingju
Responsible Party
Sponsor Investigator
Principal Investigator

liuxingju

Researcher

Ministry of Science and Technology of the People´s Republic of China

Eligibility Criteria

Inclusion Criteria

  • with diagnosed complex intracranial aneurysm by digital subtraction angiography(DSA);
  • got SAH in history;
  • neural functional deficits due to aneurysms;
  • with \<4 in Hunt-Hess Grades;
  • ≥5.0mm in the maximum diameter;
  • \<70 years old;
  • with irregular morphological features and high rupture risk.

Exclusion Criteria

  • \>70 in age, with low rupture risk;
  • cannot tolerant the operation;
  • patient or relative refuses to participate the trail;
  • SAH patient with ≥4 Hunt-Hess grading system;
  • \<5.0mm in the maximum diameter.

Outcomes

Primary Outcomes

operation-related mortality rate

Time Frame: From the time of operation begin to 48 hours after operation

the mortality rate related to the operation

Secondary Outcomes

  • Morbidity rate of peri-operative intracranial ischemic events(From date of admission to 7 days after operation)
  • Residual rate of aneurysms(the date of first post-operative cerebrovascular angiography is conducted, up to 3 months after operation)
  • Morbidity rate of neural functional deterioration in 48 hours after operation(48 hours after operation, ±6 hours)
  • Duration of total operating time(through study completion, an average of 1 year)
  • Morbidity rate of peri-operative intracranial hemorrhage(From date of admission to the 7 days after operation)
  • Morbidity rate of neural functional deterioration in 12 months(the 12th month after operation, ±1 week)
  • Treatment-related costs(through study completion, an average of 1 year)
  • Duration of hospitalization(through study completion, an average of 1 year)
  • Morbidity rate of neural functional deterioration in 7 days(7 days after operation, ±2 days)
  • Morbidity rate of neural functional deterioration in 3 months(the 3rd month after operation, ±1 week)
  • Morbidity rate of neural functional deterioration in 6 months(the 6th month after operation, ±1 week)

Study Sites (1)

Loading locations...

Similar Trials